We are live on
!
Find out more
BFA
BlackRock Fund Advisors Portfolio holdings
AUM
$542B
1-Year Est. Return
18.13%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$355B
AUM Growth
+$17.7B
(+5.2%)
Cap. Flow
+$3.38B
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
9.86%
Holding
4,000
New
139
Increased
1,720
Reduced
1,849
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$405M |
| 2 |
Wells Fargo
WFC
|
+$296M |
| 3 |
GE Aerospace
GE
|
+$146M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$136M |
| 5 |
TIME
Time Inc.
TIME
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$199M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$191M |
| 3 |
Apple
AAPL
|
+$173M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$169M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.61% |
| 2 | Healthcare | 12.54% |
| 3 | Financials | 12.33% |
| 4 | Industrials | 11.48% |
| 5 | Energy | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNP
3501
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $193K | ﹤0.01% |
+28,237
| New | +$189K |
|
3502
First US Bancshares
FUSB
$91.9M
| $192K | ﹤0.01% |
22,670
+648
| +3% | +$5.24K |
|
|
SARA
3503
DELISTED
SARATOGA RESOURCES INC
SARA
| $192K | ﹤0.01% |
108,947
+3,112
| +3% | +$4.54K |
|
|
RHE
3504
DELISTED
Regional Health Properties, Inc.
RHE
| $191K | ﹤0.01% |
3,711
+106
| +3% | +$5.2K |
|
3505
CVD Equipment Corp
CVV
$46.7M
| $190K | ﹤0.01% |
15,668
+448
| +3% | +$5.73K |
|
|
SMED
3506
DELISTED
Sharps Compliance Corp
SMED
| $190K | ﹤0.01% |
43,084
+1,232
| +3% | +$5.09K |
|
3507
Prudential
PUK
$36.1B
| $189K | ﹤0.01% |
4,258
+17
| +0.4% | +$754 |
|
3508
Barclays
BCS
$91B
| $188K | ﹤0.01% |
13,927
+268
| +2% | +$4.06K |
|
|
AMBI
3509
DELISTED
Ambit Biosciences Corp
AMBI
| $187K | ﹤0.01% |
27,049
+776
| +3% | +$5.44K |
|
|
REED
3510
DELISTED
Reeds, Inc. Common Stock
REED
| $186K | ﹤0.01% |
710
+20
| +3% | +$5.05K |
|
|
HDSN
3511
Hudson Technologies
HDSN
$259M
| $185K | ﹤0.01% |
63,936
+1,824
| +3% | +$5.34K |
|
3512
InfuSystem Holdings
INFU
$200M
| $185K | ﹤0.01% |
69,777
+1,992
| +3% | +$5.49K |
|
3513
Theriva Biologics
TOVX
$9.8M
| $185K | ﹤0.01% |
12
| – | – |
|
|
AIOT
3514
PowerFleet Inc
AIOT
$525M
| $185K | ﹤0.01% |
33,940
+968
| +3% | +$4.9K |
|
3515
Energous
WATT
$72.8M
| $184K | ﹤0.01% |
+20
| New | +$145K |
|
|
ENVI
3516
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
| $184K | ﹤0.01% |
76,663
+2,192
| +3% | +$5.66K |
|
|
ACFN
3517
DELISTED
Acorn Energy Inc
ACFN
| $184K | ﹤0.01% |
77,778
-549,273
| -88% | -$1.26M |
|
3518
Apyx Medical
APYX
$163M
| $183K | ﹤0.01% |
50,377
+1,440
| +3% | +$5.82K |
|
3519
National Grid
NGG
$81.3B
| $183K | ﹤0.01% |
2,550
-7
| -0.3% | -$485 |
|
3520
Unilever
UL
$144B
| $183K | ﹤0.01% |
3,588
+1
| +0% | +$50 |
|
|
ROYL
3521
DELISTED
ROYALE ENERGY INC
ROYL
| $183K | ﹤0.01% |
52,330
+1,496
| +3% | +$4.41K |
|
|
CBNK
3522
DELISTED
CHICOPEE BANCORP INC COM STK
CBNK
| $182K | ﹤0.01% |
10,706
+304
| +3% | +$5.2K |
|
3523
Achieve Life Sciences
ACHV
$634M
| $179K | ﹤0.01% |
22
-166
| -88% | -$2.04M |
|
|
DFBG
3524
DELISTED
Differential Brands Group Inc
DFBG
| $179K | ﹤0.01% |
5,639
+161
| +3% | +$5.05K |
|
|
ADGE
3525
DELISTED
American Dg Energy Inc
ADGE
| $179K | ﹤0.01% |
99,305
+2,840
| +3% | +$6.34K |
|
Similar funds
BIT
BG
BA
BIM
BJ
IC
EAM
MFS
BlackRock Fund Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Fund Advisors held 4,000 positions worth $355B, up 5.2% from $337B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
BlackRock Fund Advisors's Q2 2014 filing shows 139 new, 1,720 increased, 1,849 reduced and 134 closed positions. Its largest new stake was Endo International plc: 6,053,196 shares worth $424M. The largest sale was Pentair, an estimated $199M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
- BlackRock Fund Advisors's largest Q2 2014 buy was Endo International plc: 6,053,196 shares worth $424M.
- BlackRock Fund Advisors added most to Wells Fargo in Q2 2014, an estimated $296M increase.
- BlackRock Fund Advisors's biggest Q2 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $191M.
- BlackRock Fund Advisors fully exited Pentair in Q2 2014, selling an estimated $199M.
- BlackRock Fund Advisors's ten largest holdings make up 9.9% of its $355B portfolio in Q2 2014.
- BlackRock Fund Advisors opened 139 new positions and closed 134 in Q2 2014.
- BlackRock Fund Advisors's portfolio value rose 5.2% quarter-over-quarter to $355B.
Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.